Publication dates

All regions

Immunotherapy Industry, October 2014 Market Research & Statistics

You might be interested in: vaccine, oncology, drug, more »

1-10 of about 600 reports for Immunotherapy

Alk - Annual Report, June 2014

  • Alk Releases its Annual Report 2013
  • June 2014
    73 pages
  • Denmark  

    Europe  

View report >

Pathology Description in Europe - Forecast

  • May 2014
    5 pages
  • Melanoma  

    Drug  

  • Europe  

    Italy  

    Germany  

View report >

General Medicine And Specialty Medicine Markets in the US - Forecast

  • March 7, 2014 Friday
  • March 2014
    10 pages
  • General Medicin...  

    Oncology  

    Pathology  

  • United States  

    Europe  

    Spain  

View report >

General Medicine And Specialty Medicine Markets in the US - Forecast

  • Mci Daily Dose Equity Research Headlines: March 7, 2014
  • January 2014
    10 pages
  • General Medicin...  

    Oncology  

    Pathology  

  • United States  

    Europe  

    Spain  

View report >

Medigene - Annual Report, 2013

  • Tr Ansformation
  • January 2013
    145 pages
  • Germany  

View report >

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

Pathology Description - Forecast

  • Amgen - Annual Eps Growth (%)
  • April 2014
    9 pages
  • Pathology  

    Cancer  

    Melanoma  

  • United States  

    Europe  

View report >

Pathology Industry - Analyst Report, 2014

  • Investment Summary
  • January 2014
    6 pages
  • Pathology  

  • United States  

View report >

Pathology Description in the US - Forecast

  • In this Issue
  • January 2013
    17 pages
  • Cancer  

  • United States  

View report >

Medinet - Annual Report, 2013

  • Http://www.edgar-online.com
  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >
39 reports for Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 6 813)

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.